SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based ...

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Illumina (ILMN) to $180 from $184 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech ...

With a Zacks Rank #1 (Strong Buy) at present, the global diagnostics company is gaining more market shares from the strength of the Afirma solution. Veracyte is also making strides with the Decipher ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Background: Immunoglobulin-related genes are associated with the favorable prognosis of triple-negative breast cancer (TNBC) patients. We aimed to analyze the function and prognostic value of ...

The simplest way to install SpliceAI is through pip or conda: ...

Formerly head of Illumina’s strategy and market intelligence teams, as well as general manager of its companion diagnostics business, Vaz will also sit on Pleno’s board of directors.

After hours: 3 January at 19:53:14 GMT-5 ...

The TapeStation system allows for automated electrophoresis of most DNA and RNA samples. Typical applications include quality control (QC) of NGS libraries and RNA extractions (ie. RIN). This method ...